Does a Baby Aspirin a Day Keep the Doctor Away? A Review of Primary Prevention Strategies for Atherosclerotic Cardiovascular
Tracking # 20-892399
Price not reported
5
(1 ratings)
Educator ADVENTHEALTH DEPARTMENT OF PHARMACY
CE Broker Reporting Reported automatically
Method Lecture
Dates Contact provider
Course overview
At the end of this presentation, the pharmacists will be able to: 1. Recognize the disease states and risk factors encompassed in cardiovascular disease (CVD) versus atherosclerotic cardiovascular disease (ASCVD) 2. Explain the pathophysiological role of aspirin, antihypertensives, and statin therapy in ASCVD primary prevention and understand key points from recent clinical trials and/or meta-analyses 3. Develop patient-specific recommendations for ASCVD primary prevention
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Pharmacy
Pharmacist
1h
General
Registered Pharmacy Technician
1h
General
Disclosure statements
Neither my family nor I have a financial relationship with any healthcare related proprietary entity.